100,000th Robotic-Arm Assisted Joint Replacement Procedure Performed in the U.S. with Stryker's Mako System
MAHWAH, N.J., June 6, 2017 /PRNewswire/ -- Stryker Orthopaedics celebrated a landmark moment this month as the 100,000(th) cumulative robotic-arm assisted procedure in the U.S. was performed using the Mako System.(1 ) This advanced robotic technology transforms the way joint replacement surgery is performed, enabling surgeons to have a more predictable surgical experience with increased accuracy.(2,3,4,5)
"This milestone demonstrates strong continuing acceptance of this technology and highlights how together with our customers we are creating the future by growing the robotics market," said Bill Huffnagle, President of Stryker's Joint Replacement Division. "We look forward to continuing to offer this advanced procedure to more surgeons nationwide."
Through CT-based 3D modeling of bone anatomy, surgeons can use the Mako System to create a personalized surgical plan and identify the implant size, orientation and alignment based on each patient's unique anatomy. The Mako System also enables surgeons to virtually modify the surgical plan intra-operatively and assists the surgeon in executing bone resections.
Earlier this year, Stryker announced the commercial launch of its highly anticipated robotic-arm assisted application, Mako Total Knee, for use with the market leading Triathlon Total Knee System. This latest advancement distinguishes the Mako System as the first and only robotic technology that can be used across the joint replacement service line to perform total knee, partial knee and total hip replacements. These treatment options are designed to relieve the pain caused by joint degeneration due to osteoarthritis.
About Stryker
Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world.
1. Stryker Sales Data, June 1, 2017
2. Nawabi DH, Conditt MA, Ranawat AS, Dunbar NJ et al. Haptically guided
robotic technology in total hip arthroplasty: a cadaveric investigation.
J Engineering in Medicine. 2012;227(3):302-309.
3. Illgen R. Robotic assisted total hip arthroplasty improves accuracy and
clinical outcome compared with manual technique. 44th Annual Advances in
Arthroplasty Course. October 7-10, 2014, Cambridge, MA.
4. Anthony I, Bell SW, Blyth M, Jones B et al. Improved accuracy of
component positioning with robotic-assisted unicompartmental knee
arthroplasty. J Bone Joint Surg Am. 2016;98-A(8):627-35.
5. Hampp EL, Scholl LY, Prieto M, Chang T, Abbasi AZ, Bhowmik-Stoker M, Otto
JK, Jacofsky DJ, Mont MA. "Accuracy Assessment of Robotic and Manual TKA
in a Cadaveric Model." Robotic-arm assisted total knee arthroplasty
demonstrated greater accuracy to plan compared to manual technique. ORS
2017 Annual Meeting. San Diego. Poster No.2412.
IMPORTANT INFORMATION
Hip & Knee Replacements
Hip joint replacement is intended for use in
individuals with joint disease resulting
from degenerative and rheumatoid arthritis,
avascular necrosis, fracture of the neck of
the femur or functional deformity of the
hip. Knee joint replacement is intended for
use in individuals with joint disease
resulting from degenerative, rheumatoid and
post-traumatic arthritis, and for moderate
deformity of the knee.
Joint replacement surgery is not appropriate
for patients with certain types of
infections, any mental or neuromuscular
disorder which would create an unacceptable
risk of prosthesis instability, prosthesis
fixation failure or complications in
postoperative care, compromised bone stock,
skeletal immaturity, severe instability of
the joint, or excessive body weight.
Like any surgery, joint replacement surgery
has serious risks which include, but are
not limited to, pain, bone fracture, change
in the treated leg length (hip), joint
stiffness, hip joint fusion, amputation,
peripheral neuropathies (nerve damage),
circulatory compromise (including deep vein
thrombosis (blood clots in the legs)),
genitourinary disorders (including kidney
failure), gastrointestinal disorders
(including paralytic ileus (loss of
intestinal digestive movement)), vascular
disorders (including thrombus (blood
clots), blood loss, or changes in blood
pressure or heart rhythm), bronchopulmonary
disorders (including emboli, stroke or
pneumonia), heart attack, and death.
Implant related risks which may lead to a
revision of the implant include
dislocation, loosening, fracture, nerve
damage, heterotopic bone formation
(abnormal bone growth in tissue), wear of
the implant, metal sensitivity, soft tissue
imbalance, osteolysis (localized
progressive bone loss), audible sounds
during motion, and reaction to particle
debris.
The information presented is for educational
purposes only. Speak to your doctor to
decide if joint replacement surgery is
appropriate for you. Individual results
vary and not all patients will return to
the same activity level. The lifetime of
any joint replacement is limited and
depends on several factors like patient
weight and activity level. Your doctor will
counsel you about strategies to potentially
prolong the lifetime of the device,
including avoiding high-impact activities,
such as running, as well as maintaining a
healthy weight. It is important to closely
follow your physician's instructions
regarding post-surgery activity, treatment
and follow-up care. Ask your doctor if a
joint replacement is right for you.
Contact: Jeanine Guilfoyle Stephanie Bostaph
Stryker Orthopaedics Ketchum
201-831-6277 703-229-2849
jeanine.guilfoyle@stryker.com stephanie.bostaph@ketchum.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/100000th-robotic-arm-assisted-joint-replacement-procedure-performed-in-the-us-with-strykers-mako-system-300469080.html
SOURCE Stryker Orthopaedics
